What are you looking for?

Patient Recruitment Case Study: COVID-19

A phase 3 clinical trial evaluating the efficacy and safety of an investigational drug to reduce the risk of blood clots, stroke, and heart attack due to COVID-19

A phase 3 clinical trial evaluating the efficacy and safety of an investigational drug to reduce the risk of blood clots, stroke, and heart attack due to COVID-19

THE CLINICAL TRIAL
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. While the disease caused mild-to moderate respiratory symptoms in many, some experienced severe illness with serious complications, such as blood clots that could lead to heart attack stroke, hospitalization, or even death. The purpose of the PREVENT-HD Trial was to evaluate if an investigational drug could prevent these complications.

 

THE PROJECT
The pandemic was an anxiety-filled two years that turned our routines upside down. Misinformation and disinformation were running rampant, causing an unprecedented distrust in the scientific community. There was no vaccine available at this time, and very little was known about COVID-19 symptoms and complications. Our approach focused on breaking through to patients during this stressful time and educating patients at the ever-changing point of care.

KEY OUTCOMES

  • Saved 4% of their total SaaS spend in the first 3 months, and 16% in the first year working with Zylo
  • Revealed 30% overspend in budget
  • Saved 10 hours per week, allowing more focus on strategic work
  • 75 contracts negotiated by Zylo in year one
  • Reduced number of applications by 10% while experiencing rapid growth
Patient recruitment covid-19 clinical study poster branding and content development
Patient recruitment covid-19 clinical study poster branding and content development
Patient recruitment covid-19 clinical study messaging strategy

Engaging patients at a new point-of-care.

    With healthcare offices closed, we had to find a different way to reach potential participants. The only time in-person visits occurred for non-emergency care often was during drive-through COVID-19 testing. We supplied these sites with study materials for the medical staff to distribute as they administered COVID-19 tests to raise awareness of the complications and the clinical trial opportunity. After test results came back, sites contacted those who tested positive to discuss the clinical trial further.
Patient recruitment covid-19 clinical study messaging strategy
Patient recruitment covid-19 clinical study study roadmap branding and content development
Patient recruitment covid-19 clinical study study schematic branding and content development
Patient recruitment covid-19 clinical study study roadmap branding and content development

Breaking through the noise with simplicity.

COVID-19 was at the top of everyone’s mind, but with very little being know about the disease symptoms at that time, the blot clot-related complications were not. Focusing on education, we embraced the simplicity of the trial design to position against the complexity of the current healthcare situation. We developed a brand identity with a clean visual style and clear, concise messaging, inspired by medical public service announcements, to quickly educate potential participants about the possibility of dangerous blood clots and how they could easily make a difference by participating.

Patient recruitment covid-19 clinical study study schematic branding and content development

Learn how we can put our patient recruitment solutions to work for your next clinical trial.

Back Top